2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Future oncology (London, England)
PubMed • Publisher's siteUpdate your location to show providers, locations, and services closest to you.
Cancer Specialist (Oncologist), Hematology and Oncology Specialist
11 publications
2023
Future oncology (London, England)
PubMed • Publisher's site2023
BMJ case reports
PubMed • Publisher's site2023
Journal of hepatocellular carcinoma
PubMed • Publisher's site2023
Cancer control : journal of the Moffitt Cancer Center
PubMed • Publisher's site2023
Cancers
PubMed • Publisher's site